The REVEAL Study
Ishibashi, Tatsuro, MD, Li, Xiaoxin, MD, Koh, Adrian, MD, FRCS(Ed), Lai, Timothy Y.Y., MD, FRCOphth, Lee, Fenq-Lih, MD, Lee, Won-Ki, MD, PhD, Ma, Zhizhong, MD, Ohji, Masahito, MD, Tan, Nikolle, MD, Cha, Sung Bok, MD, Shamsazar, Jila, PhD, Yau, C. Lillian, PhD
Published in Ophthalmology (Rochester, Minn.) (01.07.2015)
Published in Ophthalmology (Rochester, Minn.) (01.07.2015)
Get full text
Journal Article
The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema
Ishibashi, Tatsuro, Li, Xiaoxin, Koh, Adrian, Lai, Timothy Y Y, Lee, Fenq-Lih, Lee, Won-Ki, Ma, Zhizhong, Ohji, Masahito, Tan, Nikolle, Cha, Sung Bok, Shamsazar, Jila, Yau, C Lillian
Published in Ophthalmology (Rochester, Minn.) (01.07.2015)
Published in Ophthalmology (Rochester, Minn.) (01.07.2015)
Get full text
Journal Article
EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Zhao, Jialiang, Li, Xiaoxin, Tang, Shibo, Xu, Gezhi, Xu, Xun, Zhang, Feng, Zhang, Meixia, Shamsazar, Jila, Pilz, Stefan, Nieweg, Annette
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.12.2014)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.12.2014)
Get full text
Journal Article
A Phase II Study of Oral Panobinostat (LBH589) in Accelerated Phase (AP) or Blast Crisis (BC) Chronic Myeloid Leukemia (CML) Patients Resistant to ≥2 BCR-ABL Tyrosine Kinase Inhibitors
Guilhot, François, Dubruille, Viviane, Skotnicki, Aleksander B., Hellmann, Andrey, Shamsazar, Jila, Bourquelot, Priscille M., Jalaluddin, Muhammad, Li, Martha, Abruzzese, Elisabetta, Akard, Luke
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
A Phase II Study of Oral Panobinostat (LBH589) for Chronic Phase Chronic Myeloid Leukemia (CML) with Resistance to ≥2 BCR-ABL Tyrosine Kinase Inhibitors
Zaritskey, Andrey, Alimena, Giuliana, Konopka, Lech, Shamsazar, Jila, Bourquelot, Priscille M., Jalaluddin, Muhammad, Li, Martha, Turkina, Anna, Ossenkoppele, Gert J., Goldberg, Stuart L., Powell, Bayard
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article